Surrozen, Inc./DE (SRZN) Net Margin
- 2026-06-30: Net Margin 1003.54%.
- 2026-03-31: Net Margin -2550.10%.
- 2025-12-31: Net Margin -34689.20%.
- 2025-09-30: Net Margin -7288.20%.
Complete source-backed net margin history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | 1003.54% |
| 2026-03-31 | -2550.10% |
| 2025-12-31 | -34689.20% |
| 2025-09-30 | -7288.20% |
| 2025-06-30 | 4043.34% |
| 2025-03-31 | -2743.64% |
| 2024-12-31 | -4280.76% |
| 2024-09-30 | -14.34% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -6960.77% |
| 2024-12-31 | -596.56% |
| 2022-12-31 | -288.03% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |